Surgical Resection of Latent Brain Tumors Prior to Recurrence

This clinical trial evaluates the side effects and possible benefits of operating on brain tumors prior to the tumor coming back (recurrence). Understanding when surgery is most useful to patients with brain tumors is important. Some patients may undergo chemotherapy or radiation but still have visible tumor remaining after treatment. The purpose of this research is to compare outcomes of those who have surgery after chemotherapy or radiation, but prior to tumor recurrence, to those who have surgery at a different time, or no surgery at all.

Trial Details

NCT ID
NCT04810871
Phase
NA
Sponsor
Mayo Clinic
Status
RECRUITING
Cancer Type
Brain Cancer
Interventions
  • Brain Surgery
Locations (sample)
  • Rochester, Minnesota, United States|44.02163,-92.4699

Key Eligibility Criteria

  • Age \>= 18 years
  • Histological or cytological confirmation of brain tumor and/or suspected brain tumor based on clinical and radiologic findings
  • Prior chemotherapy and/or radiation treatment directed to the known/suspected tumor
  • Radiographic evidence of residual or previously unresected tumor

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Brain Cancer Trials on Trialify →